Cargando…

Systemic Mastocytosis in Association with Small Lymphocytic Lymphoma

Patient: Female, 59 Final Diagnosis: Systemic mastocytosis in association with small lymphocytic lymphoma Symptoms: Skin rash Medication: — Clinical Procedure: Bone marrow biopsy Specialty: Hematology OBJECTIVE: Rare disease BACKGROUND: Systemic mastocytosis with an associated hematologic non-mast c...

Descripción completa

Detalles Bibliográficos
Autores principales: Iqbal, Muhammad F., Soriano, Paolo Marco K., Nagendra, Sanjai, Sana, Sherjeel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5637574/
https://www.ncbi.nlm.nih.gov/pubmed/28970467
http://dx.doi.org/10.12659/AJCR.905759
Descripción
Sumario:Patient: Female, 59 Final Diagnosis: Systemic mastocytosis in association with small lymphocytic lymphoma Symptoms: Skin rash Medication: — Clinical Procedure: Bone marrow biopsy Specialty: Hematology OBJECTIVE: Rare disease BACKGROUND: Systemic mastocytosis with an associated hematologic non-mast cell lineage disease is a rare entity, and the majority of systemic mastocytosis cases are associated with myeloid neoplasm. Lymphoproliferative disorders are less commonly associated with systemic mastocytosis and a few cases of systemic mastocytosis associated with chronic lymphocytic leukemia have been described in the literature. CASE REPORT: We present a case of indolent systemic mastocytosis associated with small lymphocytic lymphoma. The bone marrow biopsy demonstrated mast cells in the form of clusters and perivascular distribution on immunohistochemistry for tryptase, CD2, and CD25 markers. In addition, 30% involvement by small lymphocytic lymphoma was discovered in the form of interstitial lymphoid aggregates composed of small lymphocytes. Flow cytometry showed B-cells positively stained for CD19, CD20, CD5, CD23, and kappa light chains, and the CD38 expression was <5%. CONCLUSIONS: In systemic mastocytosis with an associated hematologic non-mast cell lineage disease, the combination of systemic mastocytosis associated with small lymphocytic lymphoma is rare and the management strategy follows the principle of treating the two entities individually as if they are not related. Clinical surveillance is indicated for indolent systemic mastocytosis and low-risk small lymphocytic lymphoma to monitor for disease progression.